KRAS cancer drug eased symptoms of rare and serious blood vessel condition in two patients, new study shows

The ad­vent of new tar­get­ed on­col­o­gy ther­a­pies may ben­e­fit more than just can­cer pa­tients.

Two pa­tients with se­vere ar­te­ri­ove­nous mal­for­ma­tions — an ul­tra-rare con­di­tion where a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.